International journal of molecular medicineJul 17, 2026

Fixing lung cell problems in unexplained lung scarring: How it happens and new treatment ideas

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Jul 18, 2026

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by the replacement of functional lung tissue with fibrous cells and excessive matrix deposition, leading to respiratory failure.

Current treatment options for IPF are limited and mainly slow disease progression without reversing the underlying pathology.
Approved antifibrotic agents inhibit fibroblast growth but do not stop the disease's progression.
Type II alveolar epithelial cells (AT2) may act as facultative stem cells in the lung, offering therapeutic potential for IPF.
Key pathogenic factors in IPF include cellular aging and mechanical stress on lung tissue.
The review discusses regulatory pathways of AT2 cell behavior and evaluates strategies for improving existing therapies to better manage IPF.

Simplified

Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive form of interstitial lung pathology. It is characterized by the relentless replacement of functional alveolar epithelium by aberrant fibroblasts and excessive extracellular matrix deposition, resulting in respiratory failure. Currently, the treatment options for this disease are limited. Approved antifibrotic agents primarily slow disease progression by inhibiting fibroblast proliferation and downstream fibrotic pathways; however, they do not halt or reverse the underlying pathology. Recent studies have elucidated the proliferation and differentiation characteristics of type II alveolar epithelial (AT2) cells, identifying them as facultative stem cells of the distal lung with significant therapeutic potential in IPF. However, there are certain limitations in clinical translation. This review comprehensively summarizes the regulatory pathways governing AT2 proliferation and differentiation, and investigates key pathogenic drivers of IPF, including cellular senescence and mechanical tension. Furthermore, it evaluates current treatment strategies and methods to facilitate safer, more effective clinical delay or even reversal of pulmonary fibrosis by identifying or improving existing therapies.

Fixing lung cell problems in unexplained lung scarring: How it happens and new treatment ideas

Abstract

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief